OBJECTIVE: Susceptibility-weighted MR imaging (SWI) is usually obtained without administration of intravenous gadolinium (Gd). However, it is occasionally necessary to perform SWI after Gd is injected. The effects of Gd on SWI have not been systematically examined. The aim of this prospective study was to investigate whether performing SWI after Gd would influence the diagnostic image quality, parenchymal signal and vascular enhancement. An additional aim is to suggest potential future applications for Gd-enhanced SWI. METHODS: SWI was performed in 31 subjects before and after Gd administration. 17 cases were examined in a 1.5T scanner and the remaining 14 were scanned at 3T. The pre- and post-Gd images were analysed for signal changes in the cerebral grey matter (GM), white matter (WM) as well as for enhancement in the superficial and deep venous system. The visibility of the veins was graded on subtraction maps. RESULTS: The Gd-enhanced images showed no image quality degradation and no significant signal intensity change in the GM and WM as compared to the pre-Gd images (p>0.05). After Gd-administration significant enhancement of the venous sinuses was noticed (p<0.005), while the deep and cortical veins were poorly enhanced as confirmed by the calculated subtraction maps. The results showed no significant difference at variable MRI field strengths. CONCLUSION: It is possible to perform SWI after Gd injection without information loss or signal change in the parenchyma. The most significant difference is the enhancement of the cerebral venous sinuses. Potential future applications are discussed.
OBJECTIVE: Susceptibility-weighted MR imaging (SWI) is usually obtained without administration of intravenous gadolinium (Gd). However, it is occasionally necessary to perform SWI after Gd is injected. The effects of Gd on SWI have not been systematically examined. The aim of this prospective study was to investigate whether performing SWI after Gd would influence the diagnostic image quality, parenchymal signal and vascular enhancement. An additional aim is to suggest potential future applications for Gd-enhanced SWI. METHODS: SWI was performed in 31 subjects before and after Gd administration. 17 cases were examined in a 1.5T scanner and the remaining 14 were scanned at 3T. The pre- and post-Gd images were analysed for signal changes in the cerebral grey matter (GM), white matter (WM) as well as for enhancement in the superficial and deep venous system. The visibility of the veins was graded on subtraction maps. RESULTS: The Gd-enhanced images showed no image quality degradation and no significant signal intensity change in the GM and WM as compared to the pre-Gd images (p>0.05). After Gd-administration significant enhancement of the venous sinuses was noticed (p<0.005), while the deep and cortical veins were poorly enhanced as confirmed by the calculated subtraction maps. The results showed no significant difference at variable MRI field strengths. CONCLUSION: It is possible to perform SWI after Gd injection without information loss or signal change in the parenchyma. The most significant difference is the enhancement of the cerebral venous sinuses. Potential future applications are discussed.
Authors: Charlie Chia-Tsong Hsu; E Mark Haacke; Chinthaka Chris Heyn; Trevor William Watkins; Timo Krings Journal: Neuroradiology Date: 2018-01-13 Impact factor: 2.804
Authors: Delia Fahrendorf; Wolfram Schwindt; Johannes Wölfer; Astrid Jeibmann; Hendrik Kooijman; Harald Kugel; Oliver Grauer; Walter Heindel; Volker Hesselmann; Andrea Bink Journal: Eur Radiol Date: 2013-08-01 Impact factor: 5.315
Authors: M El-Koussy; G Schroth; J Gralla; C Brekenfeld; R H Andres; S Jung; M A Shahin; K O Lovblad; C Kiefer; R Kottke Journal: AJNR Am J Neuroradiol Date: 2011-12-22 Impact factor: 3.825
Authors: P P Gratz; G Schroth; J Gralla; H P Mattle; U Fischer; S Jung; P Mordasini; K Hsieh; R K Verma; C Weisstanner; M El-Koussy Journal: AJNR Am J Neuroradiol Date: 2015-03-19 Impact factor: 3.825